GIORGI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 6.726
EU - Europa 3.908
AS - Asia 1.559
AF - Africa 145
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
Totale 12.372
Nazione #
US - Stati Uniti d'America 6.480
IT - Italia 1.477
SE - Svezia 728
CN - Cina 626
DE - Germania 500
VN - Vietnam 426
BG - Bulgaria 338
CA - Canada 245
TR - Turchia 206
GB - Regno Unito 187
UA - Ucraina 183
FI - Finlandia 153
SG - Singapore 125
CH - Svizzera 93
CI - Costa d'Avorio 76
HK - Hong Kong 68
GR - Grecia 55
FR - Francia 47
IN - India 46
RU - Federazione Russa 45
AT - Austria 41
NG - Nigeria 37
BE - Belgio 27
KR - Corea 26
SN - Senegal 19
IR - Iran 18
BR - Brasile 12
NL - Olanda 11
EU - Europa 9
MA - Marocco 9
AU - Australia 7
JP - Giappone 7
PL - Polonia 4
DK - Danimarca 3
EE - Estonia 3
IE - Irlanda 3
PH - Filippine 3
YE - Yemen 3
ES - Italia 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
AR - Argentina 1
BN - Brunei Darussalam 1
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
IS - Islanda 1
LV - Lettonia 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 12.372
Città #
Woodbridge 1.170
Ann Arbor 1.007
Houston 759
Milan 748
Chandler 700
Fairfield 426
Dong Ket 391
Sofia 338
Beijing 248
Jacksonville 239
Ashburn 230
Ottawa 203
Wilmington 201
Cambridge 171
Izmir 171
Seattle 171
New York 140
Princeton 127
Lawrence 117
Medford 110
Nanjing 108
Bern 93
Abidjan 76
Des Moines 66
Hong Kong 66
Jüchen 63
Alessandria 56
Serra 54
Dearborn 53
Rome 52
Florence 51
Boulder 40
Bremen 40
Nanchang 38
Lagos 37
Los Angeles 35
Vienna 35
Redwood City 33
Marseille 32
Lancaster 31
Kocaeli 29
Sacile 29
Brussels 26
North York 26
San Diego 26
Shenyang 25
Kunming 24
Helsinki 22
Pune 22
Dakar 19
Hebei 19
Grafing 18
Düsseldorf 17
Frankfurt am Main 17
Jiaxing 17
Tianjin 15
Verona 15
Boardman 14
Falls Church 14
Hefei 14
Ogden 14
Guangzhou 13
Changsha 12
Hangzhou 12
Nürnberg 12
Tabriz 12
Norwalk 11
Berlin 9
Orange 8
Philadelphia 8
Auburn Hills 7
Ningbo 7
Shanghai 7
Detroit 6
Guangdong 6
Indiana 6
Jinan 6
Lanzhou 6
London 6
Washington 6
Pisa 5
Redmond 5
Fuzhou 4
Harbin 4
Lappeenranta 4
San Francisco 4
Toronto 4
Babol 3
Borås 3
Canberra 3
Changchun 3
Copenhagen 3
Dublin 3
Huddersfield 3
Montréal 3
Sanaa 3
Singapore 3
Tallinn 3
Tokyo 3
Torino 3
Totale 9.377
Nome #
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 261
1,2,3 Triazolo[1,2-a]benzotriazoles or 2,3-Benzo-1,3a,6,6a-Tetraazapentalenes 236
1,2,3-Triazolo[1,5-a][1,3]benzodiazepine a new heterocyclic system: Synthesis, benzodiazepine receptor binding and theoretical calculations 231
1,2,3-Triazole[4,5-d]pyridazines II. New Derivatives Tested on the Adenosine Receptors 223
An 1,2,3-Triazole Derivative Bioisoster of a Potent in Vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 218
1,2,3-triazolo [4,5-d] pyridazines-V. Preparation and adenosine receptor binding of new 4-amino derivatives. 216
1,2,3-Triazolo[1,5-a][1,4]- and 1,2,3-Triazolo[1,5-a][1,5]benzodiazepine derivatives: synthesis and benzodiazepine receptor binding. 201
1,2,3-TRIAZOLE[4,5-D]PYRIDAZINES .3. SYNTHESIS OF NEW 4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARD ADENOSINE RECEPTORS 181
1,2,3-Triazolodiazepine I. Preparation and Benzodiazepine Receptor Binding of 1-Benzyl and 1-Phenethyl-1,2,3-Triazolo[4,5-d][1,4]diazepines 177
1,2,3-Triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors 173
1,2,3-Triazolo[4,5-d]-1,2,4-triazolo[4,3-b]pyridazines 173
1,2,3-TRIAZOLO[4,5-e]-1,2,4-TRIAZOLO[3,4-c]PYRIMIDINES 170
1,2,3-Triazole[4,5-d]pyridazines IV. Preparation and Adenosine Receptor Binding of New 4-and /or 7-Aminoderivatives 169
1,2,3-triazolo[1.5-a]quinazolines: synthesis, benzodiazepine receptor binding and theoretical calculations 155
1,2,3-triazolo[4,5-d]pyridazines - Part VI. New 1-substituted-4-amino derivatives and their affinity towards A(1) and A(2A) adenosine receptors 154
"One Pot" Synthesis of 2-Substituted 9-(2'-Hydroxy-3'-aminopropyl)-8-azahypoxanthines and 8-Azaadenines [5-Substituted 3-(2'-Hydroxy-3'-aminopropyl)-7-amino and 7-hyroxy- 3H-1,2,3-triazolo[4,5-d]pyrimidines] 151
Novel 8-azapurine derivatives as ligands for A3 adenosine receptors 150
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 148
Synthesis of New 3-Benzyl-5-Phenyl-7-Alkylaminothiazolo[4,5-d]pyrimidine-2(3H)-Thiones.) 143
1,2,3-TRIAZOLO[4,5-D]PYRIDAZINES. PART VI. NEW 1-SUBSTITUTED-4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARDS A1 AND A2 ADENOSINE RECEPTORS 142
N(6)-SUBSTITUTED 2-PHENYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR - A COMPARISON WITH 2-N-BUTYL ANALOGOUS DERIVATIVES .5. 141
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 138
2-Fenyl-9-benzyl-6-arylamido-8-azapurines: new potent ligands of adenosine receptors 136
N(6)-SUBSTITUTED 2-N-BUTYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR .4. 134
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 134
NEW 1,2,3-TRIAZOLO[1,5-a]QUINOXALINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS. II 131
1,2,3-Trizoles[4,5-d]piridazines. Analogues of Prostaglandin Synthesis Inhibitors 128
N-[9-(ortho-Fluorobenzyl)-2-Phenyl-8-Azapurin-6-yl]-Amides as Potent and Selective Ligands for A1 Adenosine Receptors. 126
N(6)-Substituted 2-n-Butyl-9-Benzyl-8-Azaadenines. Affinity for Adenosine A1 and A2 Receptors. IV 125
1-(1,2,3-TRIAZOL-4-YL)-BENZIMIDAZOLONES, A NEW SERIES OF HETEROCYCLIC DERIVATIVES 123
5-(4'-SUBSTITUTED-2'-NITROANILINO)-1,2,3-TRIAZOLES AS NEW POTENTIAL POTASSIUM CHANNEL ACTIVATORS. I 122
Adenosine A1 modulators: a patent update (2008 to present) 122
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 121
2,9-Disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: Synthesis, biochemical and molecular modelling studies 120
N(6)-substituted 2-phenyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. A comparison with 2-N-butyl analogous derivatives.5. 119
Xanthine Oxidase (XO). 4(5)-Aminosubstituted-5(4)-Carboxyamido-1H-1,2,3-Triazoles: a New Class of Monocyclic Triazole Inhibitors 117
N-(9-Benzyl-2-phenyl-9H-8azapurin-6-yl)-amides: A new class of A1 adenosine receptor ligands 117
N(6)CYCLOALKYL-2-PHENYL-3-DEAZA-8-AZAADENINES: A NEW CLASS OF A1ADENOSINE RECEPTOR LIGANDS. A COMPARISON WITH THE CORRESPONDING ADENINES AND 8-AZAADENINES 116
3-[(2-Ethoxyphenoxy)methyl]piperidine derivatives. Synthesis and antidepressant activity 114
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 113
8-Azapurine nucleus: a versatile scaffold for different targets 112
ERYTHRO AND THREO 2-HYDROXYNONYL SUBSTITUTED 2-PHENYLADENINES AND 2-PHENYL-8-AZAADENINES: LIGANDS FOR A1 ADENOSINE RECEPTORS AND ADENOSINE DEAMINASE 112
Studies on Specific Inhibition of Benzodiazepine Receptor Binding by Some C-Benzoyl-1,2,3-triazole Derivatives 109
Xanthine Oxidase Inhibition: Effect of a Linear Carboalkoxy Substituent on C(2) of the Nucleus of 8-Azahypoxanthine 108
Studies on 1,2,3-Triazole Derivatives as in vitro Inhibitors of Prostaglandine Synthesis 108
A QSAR study of A1adenosine receptor antagonists by a new neural network model 108
New 4-(Benzotriazol-1-yl)-1,2,3-triazole derivatives 106
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 106
Antimicrobial properties of flavonoids. 104
TRIAZOLYLBENZIMIDAZOLTHIONES AND DERIVATIVES OF THE NEW 1,2,3-TRIAZOLO[1,5-A][1,3,5]BENZOTRIAZEPINE HETEROCYCLE 104
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 103
In vitro Inhibitors of Prostaglandin Synthesis: (p-Thiosubstituted)-Benzyl Nitrogen Heterocycles 102
QSAR study on purine and 2,3-dihydropurine analogues as antitubercular agents 102
New amido derivatives as potential BKCa potassium channel activators. XI 102
Introduction of a hydroxy function on N6 8-azaadenine substituents to improve the solubility and the effectiveness of antagonists towards A1 adenosine receptors 100
Bioisosterism, enantioselectivity and molecular modeling of new effective N6- and/or N(9)-substituted 2-phenyl adenines and 8-aza analogs: different binding modes to A1 adenosine receptors 100
XANTHINE-OXIDASE (XO) - RELATIVE CONFIGURATION OF COMPLEXES FORMED BY THE ENZYME, 2-N-ALKYL-HYPOXANTHINE OR 8-N-ALKYL-HYPOXANTHINE AND 2-N-ALKYL-8-AZAHYPOXANTHINES .12. 99
Synthesis of New 1,2,3-triazolo[1,2-a]benzotriazole derivatives or substituted 2,3-benzo-1,3a,6,6a-tetraazapentalenes. II” 99
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 99
Synthesis of New 2-Substituted 9-?-D-Ribofuranosyl-8-Azahypoxanthine 97
N(6) or N(9) Substituted 2-Phenyl-8-Azaadenines: Affinity for A1 Adenosine Receptors. VII 97
Modification of the 1,2,3-Triazole Ring Present in an Effective in vitro Inhibitor of Prostaglandin Synthesis 96
Interaction of an improved model of human A1 adenosine receptor with ligands 96
THERAPEUTIC POTENTIAL OF A1 ADENOSINE RECEPTOR LIGANDS: A SURVEY OF RECENT PATENT LITERATURE 93
SUBSTITUTED 1,2,3-TRIAZOLO[1,5-A]QUINAZOLINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS 93
Structure-Activity Studies on a 1,2,3-Triazole Derivative, a Potent in vitro Inhibitor of Prostaglandin Synthesys: the Role of the Heterocyclic Ring 92
QSAR study on a novel series of 8-azaadenine analogues proposed as A1 adenosine receptor antagonists 92
Synthesis of N(6)-Substituted 2-Phenyl-8-Azaadenosines. Their Affinity for Adenosine A1 and A2 Receptors: a Comparison with the Corresponding 2-Phenyl-9-Benzyl-8-Azaadenines. 90
2-ALKYLOXYALKYLTHIOHYPOXANTHINES AS NEW POTENT INHIBITORS OF XANTHINE OXIDASE 90
NEW 1,2,3-TRIAZOLO[4,5-E]1,2,3-TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES.II 90
A 3D model of human A1 adenosine receptor. An evaluation of the binding free energy with ligands 89
THE NEW DEGREE IN TECHICHE ERBORISTICHE (HERBAL TECHNOLOGY) 89
N(9)-substituted 2-phenyl-N(6)-benzyl-8-azaadenines: A1 adenosine receptor affinity. A comparison with the corresponding N(6)-substituted 2-phenyl-N(9)-benzyl-8-azaadenines 89
SOME STRUCTURAL CHANGES ON TRIAZOLYL-BENZOTRIAZOLES AND TRIAZOLYL-BENZIMIDAZOLONES AS POTENTIAL POTASSIUM CHANNEL ACTIVATORS. III 88
Evaluation of the Quantitative Contribution of a Phenyl Group on C(2) of 8-Azaadenosine to the Binding with Adenosine Deaminase: a New Synthesis of 8-Azaadenosine. XI. 88
An initial comparison of the content of bitter substances in Cynara Scolymus L. plants obtained from rooted of shoots and micropropagation 87
Heterocyclic analogs of benzanilide derivatives as potassium channel activators. IX 85
Xanthine Oxidase (XO). Synthesis of 4(5)-Carbxyamido-5(4)-aminoalkanoyl)amino-1,2,3-triazoles and Their Cyclization to 8-Azahypoxanthines. Evaluation for Inhibition of XO. 82
Synthesis and Biological Evaluation of New Imidazole, Pyrimidine and Purine Derivatives and Analogs as Inhibitors of Xanthine Oxidase 81
Triazolyl-benzimidazolones and triazolyl-benzotriazoles: new potential potassium channel activators. II 81
Xanthine Oxidase (XO): Relative Configuration of Complexes Formed by the Enzyme, 2- or 8-n-Alkyl-hypoxanthines and 2-n-Alkyl-8-azahypoxanthines. XII 80
An 1,2,3,Triazole Derivatives Bioisoster of a Potent in vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 79
QSAR Studies on Purine and 2,3-Dihydropurine Analogues as Antitubercular Agents 78
New Chiral Inhibitors of Induced Platelet Aggregation: the Enantiomeric Specificity of (R)- and (S)-Methyl and Ethyl Esters of 1-{p-[(1-Hydroxycarbonyl)-ethyloxy]-benzyl}-1H-1,2,3-triazole as a Tool for Determining their Biological Target. 77
Chemistry of the Dihydrothiazine Ring Moiety of Cephalosporins. A Route to 3-Formoxymethyl-3-Cephem Derivatives 77
Steroeselectivity as an evidence for a double insertion of Antagonists within A1 Adenosine Receptors 76
Structural modifications of benzanilide derivatives, effective potassium channel openers. X 76
Synthesis and ADA Inhibitory Activity of New 2-Aryl-8-Azaadenosines 74
Synthesis of analogs of (±)-EHNA as potent inhibitors of ADA 73
A Method for the Synthesis of Racemic and Optically Active 2-Substituted 9-(2',3'-Dihidroxypropyl)-8-Azahypoxanthines and 8-Azaadenines 72
1,5-Diarylsubstituted 1,2,3-triazoles as potential potassium channels activators. VI. 72
NEW N6-OR N(9)-HYDROXYALKYL SUBSTITUTED 8-AZAADENINES OR ADENINES AS AFFECTIVE A1 ADENOSINE RECEPTOR LIGANDS 72
Interactions of an improved model of the the Human A1 Adenosine Receptor with Ligands 71
Interconversion of the thiazine and thiazolidine system of β -lactam antibiotics. Electrochemical cleavage of Kamiya's disulfide promoted by bromide ion 71
Synthesis and functional evaluation of Adenosine A2A receptor ligand 67
Importance of the Substituent on C(2) in the Interconversion of the Thiazine and the Thiazolidine System of b-Lactam Antibiotics 67
Synthesis of new 2-phenyladenines and 2-phenylpteridines and biological evaluation as adenosine receptor ligands 65
New amino derivatives of 1,2,3-triazolo[4,5-D]pyrimidines and their affinity towards A1 and A2A adenosune receptors 65
XANTHINE-OXIDASE INHIBITION - EFFECT OF AN N-ALKYL SUBSTITUENT ON C-2 OF THE NUCLEUS OF 8-AZAHYPOXANTHINE 64
A 3D Model of the Human A1 Adenosine Receptor. An Evaluation of the Binding Free-Energy with Ligands 64
Totale 11.477
Categoria #
all - tutte 26.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.886


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019532 0 0 0 0 0 0 0 0 0 246 171 115
2019/20201.603 193 174 67 87 144 222 182 90 137 113 170 24
2020/20211.109 76 35 50 43 105 38 54 72 54 87 46 449
2021/20221.459 16 119 20 110 259 198 15 100 87 14 91 430
2022/20231.873 254 240 118 208 217 239 30 138 304 7 101 17
2023/20241.793 319 238 365 218 313 224 29 56 25 6 0 0
Totale 12.438